BCIC vs CRL · P/E 32, $92.3M cap vs rev $4.05B
BCP Investment Corp. (BCIC) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
BCP Investment Corp. (BCIC) is a asset management company listed on NASDAQ.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
BCIC does not have a complete income-statement cache yet.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
BCIC currently screens at market cap $92.3M and trailing P/E 32.4. CRL currently screens at market cap $7.78B.
Not investment advice. Open the BCIC and CRL stock pages for the full models.
Not investment advice.